Year |
Citation |
Score |
2022 |
Lang C, Roy S, Wang Y, Graves D, Xu Y, Serezani CH, Korrer M, Kim YJ. Efferocytosis drives myeloid NLRP3 dependent inflammasome signaling secretion of IL-1β to promote tumor growth. Frontiers in Immunology. 13: 993771. PMID 36439171 DOI: 10.3389/fimmu.2022.993771 |
0.383 |
|
2018 |
van Montfoort N, Borst L, Korrer MJ, Sluijter M, Marijt KA, Santegoets SJ, van Ham VJ, Ehsan I, Charoentong P, André P, Wagtmann N, Welters MJP, Kim YJ, Piersma SJ, van der Burg SH, et al. NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines. Cell. PMID 30503208 DOI: 10.1016/j.cell.2018.10.028 |
0.424 |
|
2018 |
Zeng Q, Fu J, Korrer M, Gorbounov M, Murray PJ, Pardoll DM, Masica DL, Kim YJ. Caspase-1 from Human Myeloid Derived Suppressor Cells Can Promote T-cell independent Tumor Proliferation. Cancer Immunology Research. PMID 29653983 DOI: 10.1158/2326-6066.Cir-17-0543 |
0.543 |
|
2017 |
Gadkaree SK, Fu J, Sen R, Korrer MJ, Allen C, Kim YJ. Induction of tumor regression by intratumoral STING agonists combined with anti-programmed death-L1 blocking antibody in a preclinical squamous cell carcinoma model. Head & Neck. PMID 28323387 DOI: 10.1002/hed.24704 |
0.416 |
|
2016 |
Korrer MJ, Zhang Y, Routes JM. Correction: Possible Role of Arginase-1 in Concomitant Tumor Immunity. Plos One. 11: e0153122. PMID 27031640 DOI: 10.1371/Journal.Pone.0153122 |
0.472 |
|
2015 |
Korrer MJ, Routes JM. Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D. Results in Immunology. 5: 1-5. PMID 25685658 DOI: 10.1016/J.Rinim.2015.01.001 |
0.507 |
|
2014 |
Korrer MJ, Routes JM. Possible role of arginase-1 in concomitant tumor immunity. Plos One. 9: e91370. PMID 24614600 DOI: 10.1371/Journal.Pone.0091370 |
0.553 |
|
Show low-probability matches. |